Accord Healthcare to move hydroxychloroquine production to UK to avoid shortages

Accord plans to produce ~70% of UK’s current annual use of hydroxychloroquine at its facility in north east of England by Oct 2020.It is importing 50 tonnes of raw chemical materials to produce the active pharmaceutical ingredient which will be enough to produce 60million tablets


Pharmaceutical Journal